Explore
MedicinehospitalEssential

Denosumab

Injection that slows bone breakdown to treat osteoporosis in people at high fracture risk.

Clinical information

Common uses

  • osteoporosis in postmenopausal women and men
  • glucocorticoid-induced osteoporosis
  • bone loss during hormone-blocking cancer treatment

Common side effects

  • back pain
  • pain in arms or legs
  • muscle and bone pain
  • high cholesterol
  • bladder infection

Cautions

  • severe low calcium, especially in advanced kidney disease — can be fatal
  • jaw bone damage (osteonecrosis) has been reported
  • unusual thigh fractures and spine fractures after stopping
  • serious infections and skin reactions can occur

Interactions

  • calcimimetic drugs — may worsen low calcium
  • other denosumab products — do not use together

Pregnancy: avoid — can harm an unborn baby

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, Bosaya (denosumab-kyqq) label, setid 1e5e8c88-3c65-3076-e44b-02d92c2d343d (accessed 2026-08-16)

Approved brands & formulations2

Brand nameDosage formStrengthImporterCategory
DenosumabParenteral ( Injection )60mgMFDA designated importers with Pre Authorization approval before importhospital
DenosumabParenteral ( Injection )120mg/1.7mLMFDA designated importers with Pre Authorization approval before importhospital
Old search API